These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 19743945)

  • 1. Creating context for the use of DNA adduct data in cancer risk assessment: II. Overview of methods of identification and quantitation of DNA damage.
    Himmelstein MW; Boogaard PJ; Cadet J; Farmer PB; Kim JH; Martin EA; Persaud R; Shuker DE
    Crit Rev Toxicol; 2009; 39(8):679-94. PubMed ID: 19743945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of tamoxifen DNA adducts using on-line sample preparation and HPLC-electrospray ionization tandem mass spectrometry.
    Gamboa da Costa G; Marques MM; Beland FA; Freeman JP; Churchwell MI; Doerge DR
    Chem Res Toxicol; 2003 Mar; 16(3):357-66. PubMed ID: 12641436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Creating context for the use of DNA adduct data in cancer risk assessment: I. Data organization.
    Jarabek AM; Pottenger LH; Andrews LS; Casciano D; Embry MR; Kim JH; Preston RJ; Reddy MV; Schoeny R; Shuker D; Skare J; Swenberg J; Williams GM; Zeiger E
    Crit Rev Toxicol; 2009; 39(8):659-78. PubMed ID: 19743944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exposure biomarkers for the study of toxicological impact on carcinogenic processes.
    Farmer PB
    IARC Sci Publ; 2004; (157):71-90. PubMed ID: 15055291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-performance liquid chromatography electrospray ionization tandem mass spectrometry for the detection and quantitation of benzo[a]pyrene-DNA adducts.
    Beland FA; Churchwell MI; Von Tungeln LS; Chen S; Fu PP; Culp SJ; Schoket B; Gyorffy E; Minárovits J; Poirier MC; Bowman ED; Weston A; Doerge DR
    Chem Res Toxicol; 2005 Aug; 18(8):1306-15. PubMed ID: 16097804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applications of mass spectrometry for quantitation of DNA adducts.
    Koc H; Swenberg JA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Oct; 778(1-2):323-43. PubMed ID: 12376138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of 32P-postlabeling and HPLC-FD analysis of DNA adducts in rats acutely exposed to benzo(a)pyrene.
    Godschalk RW; Vermeer IT; Kriek E; Floot B; Schilderman PA; Moonen EJ; Kleinjans JC; van Schooten FJ
    Chem Biol Interact; 1997 Apr; 104(1):41-54. PubMed ID: 9158694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proceedings of a workshop on DNA adducts: biological significance and applications to risk assessment Washington, DC, April 13-14, 2004.
    Sander M; Cadet J; Casciano DA; Galloway SM; Marnett LJ; Novak RF; Pettit SD; Preston RJ; Skare JA; Williams GM; Van Houten B; Gollapudi BB
    Toxicol Appl Pharmacol; 2005 Oct; 208(1):1-20. PubMed ID: 16164957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ECNIS-sponsored workshop on biomarkers of exposure and cancer risk: DNA damage and DNA adduct detection and 6th GUM-32P-postlabelling workshop, German Cancer Research Center, Heidelberg, Germany, 29-30 September 2006.
    Arlt VM; Frei E; Schmeiser HH
    Mutagenesis; 2007 Jan; 22(1):83-8. PubMed ID: 17158788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polycyclic aromatic hydrocarbon-DNA adducts in humans: relevance as biomarkers for exposure and cancer risk.
    Kriek E; Rojas M; Alexandrov K; Bartsch H
    Mutat Res; 1998 May; 400(1-2):215-31. PubMed ID: 9685648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of cisplatin 1,2-intrastrand guanine-guanine DNA adducts in human leukocytes by high-performance liquid chromatography coupled to inductively coupled plasma mass spectrometry.
    Harrington CF; Le Pla RC; Jones GD; Thomas AL; Farmer PB
    Chem Res Toxicol; 2010 Aug; 23(8):1313-21. PubMed ID: 20666396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinogen macromolecular adducts and their measurement.
    Poirier MC; Santella RM; Weston A
    Carcinogenesis; 2000 Mar; 21(3):353-9. PubMed ID: 10688855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitation of benzo[a]pyrene-DNA adducts by postlabeling with 14C-acetic anhydride and accelerator mass spectrometry.
    Goldman R; Day BW; Carver TA; Mauthe RJ; Turteltaub KW; Shields PG
    Chem Biol Interact; 2000 Jun; 126(3):171-83. PubMed ID: 10862816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statistical calculation of detection limits for DNA adducts using the 32P-postlabeling assay with a standard addition procedure.
    Lutz WK; Lutz U; Gaylor DW
    Mutat Res; 2002 Jul; 518(2):195-203. PubMed ID: 12113770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of methods for measuring biological markers of formaldehyde exposure.
    Fennell TR
    Res Rep Health Eff Inst; 1994 Jun; (67):1-20; discussion 21-6. PubMed ID: 7917119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrospray ionization-tandem mass spectrometry and 32P-postlabeling analyses of tamoxifen-DNA adducts in humans.
    Beland FA; Churchwell MI; Doerge DR; Parkin DR; Malejka-Giganti D; Hewer A; Phillips DH; Carmichael PL; Gamboa da Costa G; Marques MM
    J Natl Cancer Inst; 2004 Jul; 96(14):1099-104. PubMed ID: 15265972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA adducts in biomonitoring.
    Hemminki K
    J Occup Environ Med; 1995 Jan; 37(1):44-9. PubMed ID: 7620942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of DNA adducts to identify human health risk from exposure to hazardous environmental pollutants: the increasing role of mass spectrometry in assessing biologically effective doses of genotoxic carcinogens.
    Farmer PB; Singh R
    Mutat Res; 2008; 659(1-2):68-76. PubMed ID: 18468947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid peroxidation-induced DNA damage in cancer-prone inflammatory diseases: a review of published adduct types and levels in humans.
    Nair U; Bartsch H; Nair J
    Free Radic Biol Med; 2007 Oct; 43(8):1109-20. PubMed ID: 17854706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of human exposure to carcinogens by measurement of alkyl-DNA adducts using immunoaffinity clean-up in combination with gas chromatography-mass spectrometry and other methods of quantitation.
    Shuker DE; Bartsch H
    Mutat Res; 1994; 313(2-3):263-8. PubMed ID: 7523910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.